Early safety study of F230 tablets in healthy volunteers
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial tests a new medicine, F230, in healthy people for the first time. The goal is to check how safe it is and how the body handles it. You might consider this if you are a healthy adult looking to help advance medical research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult between 18 and 45 years old.
- Your body mass index (BMI) is between 19 and 26.
- Men must weigh at least 110 pounds (50 kg); women at least 99 pounds (45 kg).
- You must pass a health check including blood tests, heart test, urine test, and chest X-ray.
- You have not taken part in any other clinical trial in the last 3 months.
- You have no major health issues like heart, liver, or kidney disease, asthma, or epilepsy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
This is an early-stage safety study testing a new tablet called BGM0504 in healthy volunteers. Researchers want to understand how the body handles this drug and check for any side effects.
This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.
This trial tests a new tablet called VV261 in healthy volunteers to see how safe it is and how the body processes it. It is an early study to gather important information before larger trials.
This study tests a new investigational drug called SV001 in healthy volunteers to see if it is safe and how the body handles it. It is a first-in-human trial, meaning this drug has not been tested in people before.
This trial tests the safety of a new drug called HW241045 in healthy volunteers. It helps doctors understand how the drug affects the body and if it causes any side effects.
Hear when a new Pulmonary Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.